Skip to content

Myocardial Infarction Triggers and Onset in Jordan Study 2

Myocardial Infarction Triggers and Onset in Jordan Study (MINTOR) 2

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05992012
Acronym
MINTOR 2
Enrollment
1000
Registered
2023-08-15
Start date
2023-10-01
Completion date
2023-12-25
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-term Prognosis After Acute Myocardial Infarction, Time of Onset of Acute Myocardial Infarction, Triggers of Acute Myocardial Infarction

Keywords

Acute myocardial infarction, Acute ST-segment elevation myocardial infarction, Triggers of acute myocardial infarction, Middle East, Prognosis

Brief summary

A previous study (MINTOR 1) found that 43% of ST elevation myocardial infarction (STEMI) patients in Jordan had a triggering events. Fifteen years later, with changing demographics and in the post covid-19 time, we believe that triggered acute myocardial infarction might have changed in incidence and nature of the triggering events.

Detailed description

The onset of acute ST elevation myocardial infarction (STEMI) is a complex interplay of internal circadian factors and external physical and emotional triggers. These interactions may lead to rupture of an often nonocclusive vulnerable atherosclerotic coronary plaque with subsequent formation of an occlusive thrombus. The onset of MI has a distinct pattern, with peak incidence within the first few hours after awakening, on certain days of the week, and in the winter months. Physical and emotional stresses are important triggers of acute cardiovascular events including MI. Triggering events, internal changes, and external factors vary among different geographical, environmental, and ethnic regions. Life-style changes, pharmacotherapy, and psychologic interventions may potentially modify the response to, and protect against the effects of triggering events. MINTOR 1 showed that 43% of 900+ Jordanians with STEMI were exposed to a physical or emotional triggers before the onset of the heart attack. It was also found that Friday was the day of the week that witnessed more MIs that other days of the week and that 55% of MIs occurred in the early morning hours. It is largely unknown if the frequency and types of triggers, onset time of MI, day with peak of MI incidence have changed over time in Jordan with changing population demographics, especially in the post Covid-19 times. These patients will be followed up for 3 years for occurring of incident vascular events.

Interventions

None listed

Sponsors

Jordan Collaborating Cardiology Group
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age 18 years and above. * Documented acute ST elevation myocardial infarction. * Willing to sign an informed consent. * Available contact numbers for a 3-year follow up

Exclusion criteria

* Unwilling to sign an informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Triggers of acute myocardial infarctionFrom date of study enrollment until the date of a documented exposure to a trigger, up to the time of discharge from the hospital (2-5 days).Exposure to emotional of physical triggering events before the occurrence of the heart attack
Time of onset of acute myocardial infarctionFrom date of study enrollment until the date of documenting the day and hour of onset of the heart attach, up to the time of discharge from the hospital (2-5 days)Documenting the time of onset of the chest pain that marks the onset of the myocardial infarction (expressed as day of the week (MONDAY to SUNDAY) and time of the day (00:00 hr to 24:00 hr).
Acute cardiovascular eventsFrom date of study enrollment until the date of occurrence of the first cardiovascular event (described above) up to three years after study enrollment.Occurrence of death from any cause, myocardial infarction, stroke, heart failure, repeat coronary revascularization (percutaneous or surgical).

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026